Lv41
560 积分 2023-06-06 加入
Efficacy and safety of ixekizumab in psoriatic patients: a long-term real-world retrospective multicenter study from Southern Italy
1小时前
已完结
Post-Marketing Safety Surveillance of Adalimumab, Secukinumab, and Infliximab in Hidradenitis Suppurativa: An Analysis of the FDA Adverse Events Reporting System (FAERS) Database
2天前
已完结
Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan
7个月前
已完结
Long‐term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3‐year real‐life study
7个月前
已完结
Three-Year Observational Study on the Long-Term Efficacy and Safety of Dupilumab in Elderly Patients with Severe Atopic Dermatitis
7个月前
已完结
Efficacy and safety of dupilumab in patients with prurigo nodularis
8个月前
已完结
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
8个月前
已完结
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: a nationwide study
8个月前
已完结
Concurrent therapy with dupilumab and infliximab for atopic dermatitis and Crohn's disease
8个月前
已关闭
Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis
8个月前
已完结
皖公网安备34019202002308
